Enoblituzumab (Anti-B7-H3 / CD276)
Product Specifications
CAS Number
1353485-38-7
Synonyms
MGA271
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC) . MW :150 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog